Must be the money

Houston SaaS startup closes $4.5 million Series A round of funding

Houston-based Liongard has fresh funds thanks to a $4.5 million round. Getty Images

A Houston startup has something to roar about. Information Technology automation and management company, Liongard, has closed its latest round of funding at $4.5 million.

The Series A round was lead by TDF Ventures, a software, infrastructure and services fund that has a presence in Washington D.C. and Silicon Valley. Currently, the fund is investing from its $150M Fund IV. Other Liongard investors include ‎Integr8d Capital, Gestalt Theory Venture Partners, Richard Yoo (the Founder of Rackspace Managed Hosting), and others.

The fresh funds will allow for the company to ramp up the development of its Roar platform — a software product that creates a single dashboard for all data systems including the Cloud and apps, server networks, and on-site systems to make accessing and protecting the data easier. The funds will also go toward improving and expanding account management capabilities.

"This investment will help us accelerate development and integrations to create additional visibility across the varied technology stacks that MSPs [or, managed service provider] support," saysJoe Alapat, CEO of Liongard, in a release. "Our true goal is to support MSPs across the entire client journey — automating onboarding, documentation, and insight that speeds up issue resolution — unleashing teams to operate at 10X."

The SaaS company has grown its clientbase since its 2015 launch. In spring of 2018, Liongard closed its Seed Stage round of its capital campaign at $1.3 million in investments. With these initial funds, Liongard was able to put Roar on the market in April 2018 and expand its client base — growing from two clients to now close to 200 customers in less than a year.

"Liongard is in a strategic and unique position to disrupt the way MSPs operate and manage IT for their clients," says Jim Pastoriza, managing partner of TDF Ventures, in a release. "We're looking forward to a partnership with a great team building a product that will revolutionize the MSP industry."

Alapat, who runs his company out of Station Houston, told InnovationMap in March that he had a goal for the round to raise between $3 million and $4 million, and said he thinks the company has been received well by Houston investors because Liongard offers a product that other IT management companies don't.

"No one has a unified way to look across the Cloud and network and apps and services and servers," Alapat

says. "There's plenty of different dashboards and solutions that looks at one or two of those things, but there's no single solution that consolidates all of that. That's what makes us different — that we unify all of that under one umbrella."

Trending News

Building Houston

 
 

Houston-based medical device and biotech startup Steradian Technologies has been recognized by the Bill and Melinda Gates Foundation. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

A female-founded biotech startup has announced that it has received a grant from the Bill & Melinda Gates Foundation.

Steradian Technologies has developed a breath-based collection device that can be used with diagnostic testing systems. Called RUMI, the device is non-invasive and fully portable and, according to a news release, costs the price of a latte.

“We are extremely honored to receive this award and be recognized by the Bill & Melinda Gates Foundation, a leader in global health. This funding will propel our work in creating deep-tech diagnostics and products to close the equity gap in global public health," says Asma Mirza, CEO and co-founder of Steradian Technologies, in the release. “The RUMI will demonstrate that advanced technology can be delivered to all areas of the world, ensuring the Global South and economically exploited regions receive access to high-fidelity diagnostics instead of solutions that are ill-suited to the environment.”

RUMI uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30-seconds, per the release, and will be the first human bio-aerosol specimen collector to convert breath into a fully sterile liquid sample and can be used for many applications in direct disease detection.

"As the healthcare industry continues to pursue less invasive diagnostics, we are very excited that the foundation has identified our approach to breath-based sample collection as a standout worthy of their support," says John Marino, chief of product development and co-founder. “We look forward to working with them to achieve our goals of better, faster, and safer diagnostics."

Founded in 2017, Steradian Technologies is funded and supported by XPRIZE, Johnson & Johnson’s Lung Cancer Initiative, JLABS TMCi, Capital Factory, Duke Institute of Global Health, and Johnson & Johnson’s Center for Device Innovation.

The amount granted by the Bill & Melinda Gates Foundation was not disclosed. The Seattle-based foundation is led by CEO Mark Suzman and co-chaired by Bill Gates and Melinda French Gatess.

Trending News